Dechra Pharmaceuticals PLC — Share Issue/Capital Change 2016

Feb 8, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4223O

Dechra Pharmaceuticals PLC

08 February 2016

8 February 2016

Dechra® Pharmaceuticals PLC

(Dechra or the Company) 

Additional Listing

An application has been made to the Financial Conduct Authority and the London Stock Exchange for a total of 193,000 ordinary shares of 1 pence each (the "Shares") to be admitted to the Official List.

These Shares are being reserved under a block listing and will be issued pursuant to the following scheme:

Scheme	Shares
Long Term Incentive Plan	145,000
Approved Share Option Scheme	14,000
Unapproved Share Option Scheme	34,000

These Shares will rank pari passu with the Company's existing shares in issue.  It is expected that admission will become effective on 10 February 2016. 

For further information

Suzana Cross, General Counsel and Company Secretary            

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and relates products business.  Our expertise is in the development, manufacture and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

LISLLFSEFVITIIR